Cargando…
Humoral response after a fourth “booster” dose of a Coronavirus disease 2019 vaccine following a 3-dose regimen of mRNA-based vaccination in dialysis patients
Autores principales: | Housset, Pierre, Kubab, Sabah, Hanafi, Latifa, Pardon, Agathe, Vittoz, Nathalie, Bozman, Dogan-Firat, Caudwell, Valérie, Faucon, Anne-Laure |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Society of Nephrology. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9001011/ https://www.ncbi.nlm.nih.gov/pubmed/35421509 http://dx.doi.org/10.1016/j.kint.2022.04.006 |
Ejemplares similares
-
Waning but persistent humoral response 6 months after the third dose of the mRNA BNT162b2 vaccine in hemodialysis and peritoneal dialysis patients
por: Housset, Pierre, et al.
Publicado: (2022) -
SARS-CoV-2 Antibody Response After a Third Dose of the BNT162b2 Vaccine in Patients Receiving Maintenance Hemodialysis or Peritoneal Dialysis
por: Bensouna, Ilias, et al.
Publicado: (2022) -
Réponse immunitaire vis-à-vis du vaccin BNT162b2 chez les patients hémodialysés et en dialyse péritonéale
por: Bensouna, I., et al.
Publicado: (2021) -
Fourth-dose boosters with COVID-19 mRNA vaccines well tolerated
Publicado: (2022) -
Hyalinose segmentaire et focale post-vaccination anti-SARS-CoV-2 : une association fortuite ?
por: Faucon, A.-L., et al.
Publicado: (2021)